Project Details
Description
Recombinant Human Growth Hormone (rhGH) and Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) Combination Therapy in Children with Short Stature Associated with IGF-1 Deficiency: A Three-year, Randomized, Multi-Center, Open-Label, Parallel-Group,
| Status | Finished |
|---|---|
| Effective start/end date | 2/15/08 → 5/26/16 |
Funding
- Tercica, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.